Improving Outcome Measures for Trials in Phelan-McDermid Syndrome (PMS): Development of PMS-Specific Clinician and Caregiver Impression-of-Change Measures
Your question will be sent privately to Neuren Pharmaceuticals. The company may choose to make this question public.
Start the conversation
Ask Neuren Pharmaceuticals a question about this update.
